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Trefoil factor family protein 3 affects cancellous  
bone formation in the secondary centers of ossification 
of mouse tibiae
Abstract
Background and Purpose: Trefoil factor family (TFF) is a small fam-
ily of peptides, which comprises three peptides, TFF1, TFF2 and TFF3. The 
primary sites of TFF expression and synthesis are mucous epithelia, with 
gastrointestinal mucosa being their main localization. They have a role in 
mucosal restitution and strengthening of the normal mucosal barrier. Al-
though not present in healthy articular cartilage, TFF3 is expressed in os-
teoarthritis and septic arthritis affected cartilage and promotes cartilage 
degradation in such conditions. Also, TFF3 is present in endochondral os-
sification during embryonic development. Since this implies a role for TFF3 
in the ossification process, we evaluated the histomorphometric parameters 
of the trabecular bone in the epiphyses of mouse tibiae from wild type mice 
and TFF3 knock-out mice.
Materials and Methods: Tibiae of wild-type and knock-out mice were 
isolated, fixed in 4% paraformaldehyde, paraffin embedded and cut into 6µm 
sections, which were stained using Masson’s trichrome stain. Digital photo-
graphs were taken for histomorphometry of the epiphyseal cancellous bone.
Results: Trabecular bone volume density, trabecular bone surface den-
sity and trabecular number were significantly decreased in TFF3 knock-out 
mice, when compared to wild-type mice. Trabecular separation was sig-
nificantly higher in TFF3 knock-out mice, and trabecular thickness did not 
differ significantly.
Conclusions: In addition to its impact on the cartilage degradation, our 
present study shows that TFF3 might also have a role in the formation of 
cancellous bone and its properties.
IntroductIon
Trefoil factor family (TFF) is a small family of peptides, which com-prises three peptides, TFF1, TFF2 and TFF3. Their name origi-
nates from a three-looped motif in their peptide chain, which is believed 
to be responsible for their resistance to proteolysis and hydrolysis (1–3). 
While TFF2 is a „natural dimer”, containing two trefoil domains, TFF1 
and TFF3 are monomers that contain only one, but TFF1 and TFF3 
are able to form homodimers and heterodimers via disulphide bonds 
(4–7).
The primary sites of TFF expression and synthesis are mucous epi-
thelia, with gastrointestinal mucosa being their main localization (3); 
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nevertheless, they are also found in many other organ 
systems, including nervous system, where a function of a 
neuropeptide is proposed (8–10). Trefoil factors have a 
role in strengthening the normal mucosal barrier, and at 
the same time are important for mucosal restitution after 
different types of injury (11–13). Mechanisms of TFF 
peptides’ action include an effect on cell motility and 
apoptosis, modulation of cell-cell and cell-surface con-
tacts, promoting angiogenesis and an effect on immunity 
(14–16). Such properties are invaluable in mucosal repair, 
however, they also have a role in the pathogenesis and 
advancement of different tumors, such as breast, prostate, 
lung and colorectal cancer (17–23). For this reason, trefoil 
factors in serum or other body fluids are being discussed 
as diagnostic markers of different diseases, including tu-
mors, and are also viewed as potential therapeutic agents 
or targets (5, 21, 23–26). The value of such application is 
yet to be fully confirmed, however, current research seems 
promising.
TFF3 protein is found in several avascular tissues. For 
example, its expression is found to be induced in corneal 
wounds, and to promote healing of such wounds upon 
topical administration (27). Another study showed that 
although not present in healthy articular cartilage, TFF3 
is expressed in osteoarthritis and septic arthritis affected 
cartilage, where it induces several matrix metalloprotein-
ases, promotes apoptosis, and consequently, cartilage deg-
radation (28). Cartilage degradation occurs not only under 
pathological circumstances, but also in physiological con-
ditions such as endochondral ossification during embry-
onic development, and it was interesting to see how, amaz-
ingly similar to arthritic degradation, TFF3 is expressed in 
all zones of endochondral ossification, except for the rest-
ing zone (analogous to healthy adult cartilage) (29).
Since our previous research implied that TFF3 has a 
role in the endochondral ossification, we were prompted 
to take the research further and to investigate if there are 
differences in bone quality between wild type and TFF3 
knock-out mice, particularly in the trabecular bone re-
sulting from endochondral ossification in the secondary 
ossification centers of epiphyses.
Bone strength correlates to the material and structural 
properties of bone tissue, as well as the direction of the 
biomechanical load that acts on it. The structural proper-
ties depend on the trabecular bone architecture, bone 
volume and porosity, while material properties of bone 
tissue are primarily dependent on the quality of collagen 
fibers and minerals incorporated in the bone (30, 31). 
Although the very complex process of endochondral os-
sification has been investigated extensively, the origin of 
osteoblasts that produce the cancellous bone trabeculae 
still isn’t fully elucidated. Different sources of these cells 
have been considered, including perichondrial cells, hy-
pertrophic chondrocytes, pericytes of cartilage-penetrat-
ing blood vessels, and circulating progenitor cells (32). 
Recent research suggests that about sixty percent of the 
osteoblasts in endochondral bone originates from hyper-
trophic chondrocytes in endochondral ossification, and 
that, hence, hypertrophic chondrocytes have the ability 
to differentiate into osteoblasts (33). Also, it is known that 
one of the inductors of TFF3 expression in chondrocytes 
is tumor necrosis factor alpha, which is also important for 
endochondral ossification (28, 34, 35). However, results 
of previously published studies do not provide the infor-
mation about the influence of TFF3 expression on the 
bone formation, as well as would histomorphometric pa-
rameters of the bone differ in TFF3 knock-out mice.
Therefore, we hypothesized that the lack of TFF3 pro-
tein in the knock-out mice would alter the morphological 
properties of endochondral bone, for example, trabecular 
bone in the secondary centers of ossification, a direct 
product of endochondral ossification. To test this hypoth-
esis we evaluated the histomorphometric parameters of 
the trabecular bone in the epiphyses of mouse tibiae from 
wild type mice and TFF3 knock-out mice.
MAterIAls And Methods
Animals and tissue preparation
Experiments were carried out according to the guide-
lines of the Ethical Committee, Faculty of Medicine at 
the J. J. Strossmayer University in Osijek, Croatia, and in 
accordance with Croatian law regarding the handling and 
treatment of laboratory animals.
Overall 10 male mice were used for the experiment; 5 
of them were wild-type inbred mice developed by crossing 
129/Sv and c57bl/6j mice, and another 5 TFF3 knock-out 
mice (for deatails about the TFF3 knock-out mice, see 
(36)). Animals were bred and kept at the Animal Facility 
of Medical Faculty Osijek, under the conditions of 12 h 
light/dark cycles, at the average temperature of 23.5 °C 
and relative humidity 50-60%, with food and water avail-
able ad libidum. Animals were killed by cervical disloca-
tion at one month of age (28-31 days) and hind limbs were 
removed and transferred to 1×PBS (pH=7.4). Femur and 
tibia were carefully separated by cutting the ligaments, 
after which musculature and fibula were carefully re-
moved, as well as the foot.
The tibiae were fixed in freshly made 4% paraformal-
dehyde for at least 24 hrs, after which they were decalci-
fied using nitric acid. Bones were embedded in paraffin 
blocks, after which consecutive sagittal sections (6 µm 
thick) were cut using a Leica RM550 rotary microtome 
(Leica, Vienna, Austria). Representative sections of the 
middle two-thirds of the tibial epiphyses were chosen for 
the experiment, in order to expose centers of secondary 
ossification of proximal tibiae. The sections were deparaf-
finized and stained with Masson’s trichrome stain. The 
system for obtaining digital photographs for histomor-
phometric measurements of the bone sections consisted 
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of Olympus BHA microscope (Olympus, Tokyo, Japan) 
and Pulnix digital camera (Pulnix, Yokohama, Japan) 
connected to a personal computer. Digital images were 
captured under 100 × magnification and stored until the 
measurements were performed.
Bone histomorphometry
Digital photographic images were analyzed using a 
semiautomatic image analysis system that employed Issa 
software (VAMS, Zagreb, Croatia). According to the 
American Society of Bone and Mineral Research, tra-
becular bone volume density (BV/TV, in %) corresponds 
to the amount of trabecular bone within the spongy 
space. BV/TV was derived from two-dimensional (2D) 
measurements of bone area (B.Ar) and trabecular tissue 
area (T.Ar) using Parfitt’s formula, as follows (37):
BV/TV = 100B.Ar/T.Ar
Trabecular bone surface density (BS/TV, in /mm) was 
then calculated from the values for the perimetry of tra-
becular bone (B.Pm) and the area of trabecular bone 
(B.Ar)
BS/TV = B.Pm/B.Ar
In addition, three more values were calculated to eval-
uate the architecture of trabecular bone:
(1) Trabecular thickness (Tb.Th, in µm) was derived 
from measurements of the trabecular perimeter (B.Pm) 
and bone area (B.Ar) according to Parfitt’s formula:
Tb.Th = (B.Ar/B.Pm)(π/2)
(2) Trabecular number (Tb.N, in/mm) was derived 
from measurements of the trabecular perimeter (B.Pm) 
and total tissue area (T. Ar) according to the formula:
Tb.N = (B.Pm/T.Ar)×10
(3) Trabecular separation (Tb.Sp, in µm) was derived 
according to the formula:
Tb.Sp = (1000×T.Ar – B.Ar)/B.Pm
statistical Analyses
All results are expressed as median value. The data were 
analyzed using Mann-Whitney U test, and difference was 
considered significant at p<0.05
results
trabecular Bone Volume density and 
trabecular Bone surface density
Median value of trabecular bone volume density (BV/
TV, %) was significantly higher in wild-type mice group 
(44.23 %) than in the TFF3 knock-out group (23.36 %) 
(Figure 1A).
Trabecular bone surface density (BS/TV, /mm) mea-
surements showed significantly different values in the 
two groups, being higher in wild-type group (2.78 /mm), 
than in the TFF3 knock-out group (1.72 /mm) (Figure 
1B).
trabecular structure
Trabecular thickness values measured in the wild-type 
group (246.65 µm) were lower than those obtained from 
the TFF3 knock-out group (253.55 µm), however, this 
difference was not statistically significant (Figure 2A). 
Trabecular number and trabecular separation were found 
to be significantly different when comparing wild-type 
and TFF3 knock-out groups. (Figure 2, B and C). The 
trabecular number in the wild-type group was higher 
(1.48/mm) than in the TFF3 knock-out group (1.14 /
Figure 1. Trabecular bone volume density and trabecular bone surface density in tibial epiphyses of a 1 month old mice. (A) BV/TV (%) = tra-
becular bone volume density; (B) BS/TV (/mm) = trabecular bone surface density. WT = wild-type mice, T3 = TFF3 knock-out mice.
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mm), and the trabecular separation was significantly 
higher in the TFF3 knock-out (952.14 µm), than in the 
wild-type group (736.88 µm).
histological examination
Examination of the slides under the microscope, after 
the staining, reveals an obvious difference between wild-
type and TFF3 knock-out mice. TFF3 knock-out mice 
had less trabeculae in the tibial epiphysis, larger parts of 
bone marrow space was devoid of trabeculae, although, 
the thickness of the trabeculae present in the secondary 
ossification centre of the knock-out mice was similar to 
that of wild-type mice, in some animals even slightly 
thicker than that of wild-type mice. Overall, the trabecu-
lae of wild-type mice appeared more rugged (Figure 3).
dIscussIon
In this study we demonstrated that almost all of the 
examined morphometry parameters of cancellous bone 
inside the proximal tibial epiphysis were changed signifi-
cantly in TFF3 knock-out mice when compared to wild-
type mice. Overall, trabecular bone surface density and 
volume density were significantly decreased in the knock-
out animals; the trabeculae were approximately of the 
Figure 2. Trabecular thickness, number and separation in the tibial 
epiphyses of a 1 month old mice. (A) Tb.Th (µm) = trabecular 
thickness; (B) Tb.N (/mm) = trabecular number; (C) Tb.Sp (µm) 
= trabecular separation. WT = wild-type mice, T3 = TFF3 knock-
out mice.
Figure 3. Histological sections of mouse tibial epiphyses, Masson’s 
trichrome stain, magnification 100×. (A) Wild-type mouse. (B) 
TFF3 knock-out mouse.
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same thickness, however, trabecular separation was more 
pronounced, and the overall number of trabeculae was 
smaller. Therefore, our results point to the fact that the 
lack of TFF3 protein impairs bone formation in the sec-
ondary ossification centers, at least to some extent. Influ-
ence of TFF3 on chondrocyte apoptosis and the activity 
of several matrix metalloproteinases (28) is missing in 
TFF3 knock-out animals, and this might interfere with 
the natural process of cartilage degradation which would 
then contribute to reduced amount of „foundation mate-
rial” for cancellous bone formation in the epiphyseal sec-
ondary ossification centers. Since TFF proteins are shown 
to influence or to be influenced by transdifferentiation of 
different cells in the respiratory system (38–40), it may 
be hypothesized that they also play a role in transdiffer-
entiation of the hypertrophic chondrocytes into osteo-
blasts during ossification.
While TFF3 is shown to have an impact on the carti-
lage catabolism and is present in endochondral ossifica-
tion (28, 29), our present study shows that this impact of 
TFF3 on endochondral ossification seems to exceed that 
of affecting cartilage degradation, and possibly includes a 
role in the formation of cancellous bone. Some of the 
recent research showed that changes in cartilage and sub-
chondral bone are closely tied during osteoarthritis (41, 
42). Furthermore, since TFF3 is involved in the process 
of cartilage degradation and bone formation, this would 
imply possible therapeutic usage of this phenomenon.
Our knowledge about TFF peptides is constantly grow-
ing, and research on this small family of peptides has some-
what moved to areas different from that of mucosal sur-
faces, with new sites of TFF3 expression having 
developmental and clinical significance. Further experi-
ments are needed in order to more fully understand the 
impact of TFF3 on bone formation and histomorphomet-
ric parameters of the bones in TFF3 knock-out mice. More 
detailed studies on the embryonic and postnatal endo-
chondral bone formation would definitely give more in-
sight into the connection of TFF3 with this process. Also, 
similar experiments on older mice (5 or 6 months) would 
give additional insight of the final result of endochondral 
ossification. However, this is the first time that TFF3 pro-
tein was reported to be connected with morphological 
parameters of cancellous bone, and that its impact on bone 
formation is implied. Therefore, we can say that our pre-
liminary data opened some interesting and possibly fruit-
ful perspectives in the research about the TFF proteins.
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